What does VKOR stand for?

Vitamin K Epoxide Reductase

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Valley Knights Motorcycle Club (Northern California) Van Kampen Mid Cap Growth Valley Kingdom Ministries International Vancouver-Killarney Minor Lacrosse Association (Canada) Van Katholieke Maatschappelijke Organisaties (Dutch: Association of Catholic Social Organizations; Netherlands) Vorgangsknoten-Netzplan (German) Van Kabbelen Naar Stromen (Dutch: From Splash to Stream; human resources) Moscow, Russia - Vnukovo (Airport Code) Vrij Katholiek Onderwijs (Dutch; Belgian Catholic school) Volkswagen Kaplumbaga Otomobil Dernegi (Turkish: Turtle Volkswagen Automobile Association)		Vitamin K Epoxide Reductase Complex Valendia Knights of the Peace (fictional organization) Vanvasi Kalyan Parishad (Hindi: Forest Dwellers Welfare Council) Vereniging van Kunstmest Producenten (Dutch: Association of Fertilizer Producers) Very Knowledgeable Person Virtual Knowledge Park (University of Leeds; UK) Visible Knowledge Project Valsts Kulturas Piemineklu Aizsardzibas Inspekcija (Latvian: State Inspection for Heritage & Cultural Protection) Vsesoyuznaya Kommunisticheskaya Partiya Bol'shevikov (old name for Soviet Communist Party) Vereinigte Kommunistische Partei Deutschlands (German: United Communist Party of Germany)

Samples in periodicals archive:

The eQ-PCRT LC Warfarin Genotyping Kit is an in vitro diagnostic test for genotyping single nucleotide polymorphisms (SNPs) in the cytochrome P450 enzyme gene CYP2C9 known as CYP2C9*2 ( C 4 3 0 T ), C Y P 2 C 9 * 3 (A1075C), and an SNP in the vitamin K epoxide reductase complex I gene (VKORCI) Known as VKO-RC1 (-1639G>A).

Simple closed-tube real-time PCR test

Novel Oral Anticoagulant Promises Potential Benefits over Leading Treatment NEW ORLEANS -- ARYx Therapeutics (NASDAQ:ARYX) announced today that clinical data for ATI-5923, a novel vitamin K epoxide reductase (VKOR) inhibitor in Phase 2/3 development for the treatment of patients at risk of forming dangerous blood clots, were presented this week at the American Heart Association (AHA) Scientific Sessions 2008 in New Orleans, LA.

ARYx Therapeutics Presents Clinical Data for ATI-5923 at American ...

ATI-5923, like warfarin, is a selective inhibitor of VKOR, or vitamin K epoxide reductase enzyme, and has the same mechanism of anticoagulation action as warfarin.

ARYx Therapeutics Inc. Commences Phase 2/3 Clinical Trial on Oral ...

The ability to provide this test is a direct result of Clinical Data's recent execution of intellectual property licenses under which the Company has been granted commercialization rights relating to certain polymorphisms in the Vitamin K epoxide reductase complex gene (VKORC1; also known as VKOR).

Clinical Data Announces 2006 Launch of Genetic Test for Warfarin ...